e-learning
resources
Berlin 2008
Wednesday, 08.10.2008
COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Severity of lung disease in siblings with α-1-antitrypsin deficiency (AATD)
S. B. Shaker, N. Seersholm, M. Hestad, S. Andersen, L. T. Skovgaard, B. C. Stoel, A. Dirksen (Copenhagen, Denmark; Leiden, Netherlands)
Source:
Annual Congress 2008 - COPD
Session:
COPD
Session type:
E-Communication Session
Number:
4654
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. B. Shaker, N. Seersholm, M. Hestad, S. Andersen, L. T. Skovgaard, B. C. Stoel, A. Dirksen (Copenhagen, Denmark; Leiden, Netherlands). Severity of lung disease in siblings with α-1-antitrypsin deficiency (AATD). Eur Respir J 2008; 32: Suppl. 52, 4654
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Imaging of complicated pneumonia: what is new?
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Prevalence of alpha-1-antitrypsin deficiency (A1AD) in patients with COPD.
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021
Mortality in individuals with severe alpha-1-antitrypsin deficiency (PiZZ)
Source: Eur Respir J 2006; 28: Suppl. 50, 144s
Year: 2006
Treatment of lung disease in patients with AATD
Source: Eur Respir Monogr 2019; 85: 78-92
Year: 2019
Risk of cancer in individuals with severe alpha-1-antitrypsin deficiency (PiZZ) compared with the Swedish general population
Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement?
Year: 2020
Differences of disease phenotypes in individuals with alpha-1-antitrypsin deficiency with genotypes PiZZ and PiSZ - Analysis from the German registry
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Alpha-1-antitrypsin deficiency
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=139
Year: 2005
Young adult with inherited PiMZ alpha-1-antitrypsin deficiency (A1ATD)-related bronchiectasis: characteristic of blood neutrophils and A1AT protein
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016
SP-C deficiency: Three different phenotypes for the same mutation
Source: International Congress 2015 – Paediatric bronchology
Year: 2015
Screening for α1-Pi deficiency in patients with lung diseases
Source: Eur Respir J 2002; 20: 319-324
Year: 2002
Prevalence of alpha-1 antitrypsin deficiency (AATD) and frequencies of alleles PI*S and PI*Z in patients with COPD in Brazil
Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population
Year: 2013
Walking strategy in severe chronic lung disease (CLD) patients
Source: Eur Respir J 2005; 26: Suppl. 49, 309s
Year: 2005
From early origins of adult lung disease to Asthma and COPD overlap syndrome (ACOS)
Source: International Congress 2018 – Difficult paediatric lung disease
Year: 2018
Differences in the disease phenotype and comorbidities between patients with COPD and alpha-1-antitrypsin deficiency - An analysis of the COSYCONET cohort
Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Year: 2016
Alpha1-antytripsin deficiency in portuguese COPD patients
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Anemia in COPD patients of Korean obstructive lung disease (KOLD) cohort
Source: International Congress 2015 – Multidimensional analysis of respiratory problems
Year: 2015
The incidence of alpha-1-antitrypsin (A1AT) deficiency alleles in patients with pulmonary Langerhans cell histiocytosis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
Alpha 1-Antitrypsin deficiency (AATD) in patients with ARDS consequent to SARS-CoV-2 infection.
Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors
Year: 2021
Bronchiectasis in patients with alpha1-antitrypsin deficiency: prevalence and characteristics
Source: International Congress 2016 – Imaging of COPD and airways: structural and functional assessments
Year: 2016
Mortality of patients with emphysema and alpha-1-antitrypsin deficiency of Pi Z phenotype
Source: Eur Respir J 2001; 18: Suppl. 33, 25s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept